Global Erythropoietin (EPO) Market With Focus On Asia: Industry Analysis & Outlook (2016-2020)

Erythropoietin is a substance produced by the kidney that leads to the formation of red blood cells in the bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red Blood Cell production). For erythrocyte precursors present in the bone marrow, EPO acts as a cytokine. Commonly referred to as hematopoietin or hemopoietin, erythropoietin is also known to have other biological functions, such as involvement in the wound healing cycle and brain’s response to neuronal injury. People suffering from End Stage Renal Disease (ESRD), HIV or undergoing chemotherapy are not able to produce enough EPO on their own and thus, are administered with synthetic or recombinant erythropoietin which has the similar sequence of amino acids. Recombinant erythropoietin is a kind of therapeutic agent devised using DNA technology.

On the bases of their molecular structure, EPO drugs can be divided into five categories: epoetin-alfa, epoetin-beta, epoetin-omega, epoetin-delta and darbepoetin-alfa. Among these epoetin-alfa and darbepoetin-alfa are most commonly prescribed EPO drugs.

The global EPO drugs market is expected to experience negative growth rate, primarily due to expiry of patents of two most common EPO drugs, epoetin-alfa and darbepoetin-alfa, allowing the entry of biosimilars; posing a serious threat to EPO drugs market. However, the Asia-Pacific region is expected to experience boom period majorly due to improving disposable income and better government medical reimbursement policies.

The report “Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (2016-2020)” analyzes the development of this market, with focus on the US and Asia-Pacific markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Johnson & Johnson, Amgen, Roche and Teva Pharmaceutical Industries Limited are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global EPO market along with the study of the regional markets.

Download Sample copy of Report at http://www.marketresearchreports.biz/sample/sample/862810

Table of Content

1. Overview
1.1 Erythropoietin
1.2 Recombinant Human Erythropoietin (rHuEPO)
1.3 Applications of EPO and Adverse Effects

2. Global EPO Market
2.1 Global EPO Drug Market by Value
2.2 Global EPO Drug Market Forecast by Value
2.3 Global EPO Biosimilar Market by Value
2.4 Global EPO Biosimilar Market Forecast by Value
2.5 Global EPO Market by Drug Type
2.6 Global EPO Drug Market Forecast by Application
2.7 Global EPO Drug Market by Region

3. Regional Markets
3.1 The US
3.1.1 The US EPO Drug Market Forecast by Value
3.1.2 The US EPO Drugs Market by Applications
3.2 Asia-Pacific
3.2.1 China EPO Drug Market by Value
3.2.2 China EPO Drug Market Forecast by Value
3.2.3 China EPO Drug Market by Application
3.2.4 Malaysia EPO Drug Market Forecast by Value
3.2.5 Korea EPO Drug Market Forecast by Value
3.2.6 Thailand EPO Drug Market Forecast by Value
3.2.7 Philippines EPO Drug Market Forecast by Value
3.2.8 Vietnam EPO Drug Market Forecast by Value

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz

This release was published on openPR.